Similar articles

• Antilymphocytic antibodies and marrow transplantation. IV. Comparison of the effects of antibody fragments directed against immunoglobulin or lymphocyte antigens on acute secondary disease.

  Rodt H, Therfelder S, Eulitz M. Rodt H, et al. Exp Hematol. 1974;2(4):195-203. Exp Hematol. 1974. PMID: 4156327 No abstract available.
• Graft-versus-host-induced immunosuppression. The effect of antigenic stimulation on cell-mediated and humoral immune responses.

  Treiber W, Lapp WS. Treiber W, et al. Transplantation. 1973 Sep;16(3):211-6. Transplantation. 1973. PMID: 4147031 No abstract available.
• The in vivo activity of in vitro immunized mouse thymocytes. II. Rejection of skin allografts and graft-vs-host activity.

  Rouse BT, Wagner H. Rouse BT, et al. J Immunol. 1972 Dec;109(6):1282-9. J Immunol. 1972. PMID: 4404454 No abstract available.
• The double barrier in bone marrow transplantation.

  van Bekkum DW. van Bekkum DW. Semin Hematol. 1974 Jul;11(3):325-40. Semin Hematol. 1974. PMID: 4151846 Review. No abstract available.
• Active enhancement of tissue allografts with antilymphocyte serum and bone marrow.

  Monaco AP, Liegeois A, Wood ML, Clark AW. Monaco AP, et al. Adv Nephrol Necker Hosp. 1975;5:135-72. Adv Nephrol Necker Hosp. 1975. PMID: 242206 Review. No abstract available.